NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 318 filers reported holding NATERA INC in Q3 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $45,007,826 | -29.9% | 1,017,126 | -22.9% | 0.50% | -19.5% |
Q2 2023 | $64,172,808 | -21.8% | 1,318,800 | -10.8% | 0.62% | -27.6% |
Q1 2023 | $82,072,329 | +692.1% | 1,478,248 | +473.1% | 0.85% | +651.3% |
Q4 2022 | $10,361,852 | -35.8% | 257,950 | -30.0% | 0.11% | -40.2% |
Q3 2022 | $16,152,000 | -48.8% | 368,606 | -58.6% | 0.19% | -47.9% |
Q2 2022 | $31,558,000 | -19.1% | 890,452 | -7.2% | 0.36% | +2.8% |
Q1 2022 | $39,025,000 | -22.7% | 959,326 | +77.5% | 0.35% | -11.5% |
Q4 2021 | $50,467,000 | -42.4% | 540,393 | -31.3% | 0.40% | -42.0% |
Q3 2021 | $87,595,000 | -22.9% | 786,028 | -21.4% | 0.69% | -17.3% |
Q2 2021 | $113,602,000 | +151.7% | 1,000,635 | +125.1% | 0.83% | +143.3% |
Q1 2021 | $45,140,000 | -12.8% | 444,550 | -14.6% | 0.34% | -10.7% |
Q4 2020 | $51,791,000 | +7.5% | 520,407 | -22.0% | 0.38% | -9.0% |
Q3 2020 | $48,188,000 | +52.6% | 667,061 | +5.3% | 0.42% | +50.9% |
Q2 2020 | $31,575,000 | +34.3% | 633,265 | -19.6% | 0.28% | +5.7% |
Q1 2020 | $23,518,000 | -8.3% | 787,614 | +3.5% | 0.26% | +39.7% |
Q4 2019 | $25,643,000 | -10.1% | 761,155 | -12.5% | 0.19% | -15.2% |
Q3 2019 | $28,523,000 | +634.6% | 869,618 | +517.7% | 0.22% | +669.0% |
Q2 2019 | $3,883,000 | – | 140,788 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |